Assignee
RUBICON RES PRIVATE LIMITED
IN·3 granted patents·7 pending applications·4 citations·filing 2012–2025
Top patents by PatentIndex Score
10 records- 0185US10391060B2Particulate delivery systemsRUBICON RES PRIVATE LIMITED·Filed 2016·Granted Aug 27, 2019·3 cites·21 claims
- 0281US11147767B2Gastroretentive formulationsRUBICON RES PRIVATE LIMITED·Filed 2020·Granted Oct 19, 2021·1 cites·5 claims
- 0361US2025332088A1Sustained release compositionsRUBICON RES PRIVATE LIMITED·Filed 2025·Application pending·0 cites
- 0458US2021121398A1Gastroretentive formulationsRUBICON RES PRIVATE LIMITED·Filed 2020·Application pending·0 cites
- 0558US2025057789A1Stable oral liquid formulations containing metoprolol or salts thereofRUBICON RES PRIVATE LIMITED·Filed 2024·Application pending·0 cites
- 0655US10806685B2Oral care compositionsRUBICON RES PRIVATE LIMITED·Filed 2012·Granted Oct 20, 2020·0 cites·9 claims
- 0754US2024390277A1Liquid formulations of trazodoneRUBICON RES PRIVATE LIMITED·Filed 2024·Application pending·0 cites
- 0846US2021228488A1Extended release compositions and process for preparationRUBICON RES PRIVATE LIMITED·Filed 2019·Application pending·0 cites
- 0946US2022071909A1Modified release formulations of levodopaRUBICON RES PRIVATE LIMITED·Filed 2021·Application pending·0 cites
- 1043US2019262268A1Oral modified release formulationsRUBICON RES PRIVATE LIMITED·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RUBICON RES PRIVATE LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →